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Abstract
Exercise-generated signals are pro-osteogenic and anti-adipogenic within the marrow. In vitro
studies indicate that mechanical signals directly block adipogenic differentiation through
activation of β-catenin and by limiting PPARγ2 expression. Whether mechanically generated β-
catenin can inhibit adipogenesis during PPARγ transactivation is unknown. We evaluated the
ability of mechanical signals to limit adipogenesis in marrow derived mesenchymal stem cells
(mdMSC) distal to activation of PPARγ. First, we established that mdMSC attained an adipogenic
phenotype within 2-4 days in the presence of rosiglitazone (1-25 μM) and that β-catenin activation
via GSK3β inhibition interfered with this process. Similarly, mechanical strain (3600 cycles, 2%
strain daily) inhibited adipogenesis at 3 days, preventing rosiglitazone-induced PPARγ
upregulation as well as aP2 and adiponectin protein expression. To assess whether a reduction in
PPARγ expression was necessary for anti-adipogenic action, PPARγ2 was overexpressed: both
mechanical strain and GSK3β inhibition prevented expression of aP2 and adiponectin proteins
despite abundant PPARγ2 and its ligand. To understand the fate of single cells experiencing
mechanical strain we generated mdMSC from aP2-GFP reporter expressing mice. Rosiglitazone
treatment for 3 days induced GFP expression in more than 80% of cells. Sorting by GFP
expression revealed that the highest 20% of aP2-GFP expressing cells was responsible for the
majority of adipogenic protein expression. This highly expressing GFP fraction had a reduced
ability to respond to an osteogenic stimulus: BMP-2 treatment increased osterix by 12-fold in
contrast to the 42-fold increase in osterix expression that resulted from BMP-2 treatment of the
bottom 75% of GFP expressing cells. This suggested that highly expressing aP2-GFP cells
represented more terminally differentiated adipocytes, with reduced multipotentiality. Application
of mechanical strain to aP2-GFP mdMSC treated with rosiglitazone caused a two-fold decrease in
the size of the upper cell fraction, suggesting that mechanical strain preserved MSC in a
multipotent state. Our data show that mechanical strain restricts adipogenesis both by limiting
PPARγ2 expression and by preventing PPARγ action, protecting the potential of MSC to enter
other lineages.
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1. Introduction
Skeletal health over the lifetime of an organism is critically influenced by the function of the
mesenchymal and hematopoietic stem cell populations, which give rise to osteoblasts and
osteoclasts, respectively. MSC function, in terms of self-renewal and the ability to
differentiate into the osteogenic lineage, declines with aging [1], coincident with the
progression of osteoporosis. Weight-bearing exercise is beneficial to skeletal health [2, 3],
which may result in part through protective effects on mesenchymal stem cells. Prolonged
skeletal unloading, such as during immobilization or space flight, leads to reduced bone
mass and is also thought to negatively influence MSC function [4, 5]. Preservation of MSC
function is therefore important for skeletal health and appears to be influenced by exercise-
generated signals.
Bone marrow serves as a primary repository for mesenchymal stem cells. MSC
differentiation in bone marrow is primarily limited to the osteoblast and adipocyte lineages.
Accrual of marrow fat is a hallmark of aging that may negatively influence stem cell
function by promoting further adipogenesis from a limited precursor pool and through the
production of deleterious cytokines [6]. Conditions that lead to adipocyte accumulation
within the marrow, including immobilization and estrogen deficiency [7, 8], are associated
with a reduction in osteoblast progenitors. A better understanding of environmental cues that
help preserve MSC function and prevent adipogenesis within the marrow is needed.
Recent studies have shown that mechanical signals regulate MSC lineage allocation.
Exercise-generated signals are pro-osteogenic and anti-adipogenic within the marrow cavity
of rodents [9, 10], while hind limb unloading increases the potential for adipogenesis in ex
vivo marrow cultures [11]. In vitro studies indicate that mechanical signals directly block
adipogenic differentiation [12-14]. The ability of mechanical input to decrease adipogenesis
is dependent on mechanical activation of β-catenin and is at least partially due to limiting
expression of PPARγ2 [15, 16], a primary adipogenic transcription factor. Whether
mechanical factors can also interfere with adipogenesis through inhibition of PPARγ-
regulated transcription has not been determined.
PPARγ is a key transcription factor for adipocyte differentiation, with induction of target
genes supporting emergence of a mature adipogenic phenotype [17]. PPARγ may also limit
osteoblast differentiation through its ability to promote proteasomal degradation of β-catenin
[18], a critical mediator of Wnt signaling. Importantly, haploinsufficiency of PPARγ is
associated with reduced adipogenesis and augmented osteoblastogenesis [19], which
suggests a primary role for PPARγ in MSC lineage allocation. Thus it is important to
understand if mechanical factors restrict PPARγ actions, thereby enhancing the osteogenic
potential of MSC.
In this work we evaluated the ability of mechanical signals to limit adipogenesis in mdMSC
during PPARγ activation. Rosiglitazone, a thiazolidinedione PPARγ ligand, was used to
induce adipogenesis. To enable analysis of single cell differentiation, we utilized a GFP
reporter for the aP2 promoter, which is activated during adipogenesis and contains a target
sequence for PPARγ binding [20]. Our results suggest that mechanical input restrains both
PPARγ2 expression and action to preserve multipotentiality of the progenitor population.
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2. Materials and methods
2.1. Reagents
FBS was from Atlanta Biologicals (Atlanta, GA). Culture medium, trypsin-EDTA reagent,
and antibiotics were purchased from Invitrogen (Carlsbad, CA). Insulin, indomethacin, and
SB415286 were from Sigma-Aldrich (St. Louis, MO). PepMute Plus and LipoD293
transfection reagents were purchased from SignaGen Laboratories (Ijamsville, MD).
Rosiglitazone was from Cayman Chemical (Ann Arbor, MI). BMP-2 was purchased from
R&D Systems (Minneapolis, MN).
2.2. Cell culture
mdMSC were generated from C57BL/6 wild-type mice using the procedure of Peister et al
[21]. mdMSC were then plated at 3000 cells/cm2 in Iscove’s Modified Dulbecco’s Medium
containing 10% FBS and 100 μg/ml penicillin/streptomycin for expansion from passage
5-10. For experiments, mdMSC were seeded at 5,000-10,000 cells/cm2 in growth medium
(α-MEM, 10% FBS, antibiotics). Adipogenic medium consisted of 0.1 μM dexamethasone,
5 μg/ml insulin, and 5 μM rosiglitazone unless noted otherwise.
2.3. Bicolor mdMSC
C57BL/6 transgenic GFP reporter mice were intercrossed to produce the animals used to
generate bicolor mdMSC. The SMαA-GFPmCherry mice, described previously [22], show
strong expression in vascular smooth muscle and a weaker signal in the multipotential
progenitor cells that are initially expressed in a bone marrow stromal cell culture or in
rapidly regenerating bone. The aP2-GFPtopaz mouse line contains a 7.6 kb promoter
fragment of the aP2/FABP4 gene that drives the pOB4 reporter cassette containing
GFPtopaz [23]. The construct is expressed in actively forming brown and white fat in vivo
as well as macrophages in the bone marrow and spleen. Female double positive F1 mice at 8
weeks of age were used to generate bicolor mdMSC following the same culture methods
described above for the C57BL/6 wild-type mdMSC.
2.4. Transient transfection with siRNA
mdMSC were transfected with siRNA targeting β-catenin or a control nonsense siRNA at a
concentration of 20 nM using the PepMute Plus reagent in growth medium for 6 h, followed
by replacement with fresh growth medium. Experiments were initiated 24 h after
transfection.
2.5. Mechanical strain
Concurrent with the addition of adipogenic supplements, a daily strain regimen (2%
magnitude, 0.17Hz, 3600 cycles) was initiated using the Z-strain cell deformation device as
previously described [12]. For strain experiments, mdMSC were plated on collagen-I coated
silicone membranes.
2.6. PPARγ2 overexpression
The FLAG-PPARγ2 plasmid was a gift from Dr. Monte Willis (UNC-Chapel Hill). mdMSC
were transfected with pcDNA3.1(-)PPARγ2 or pcDNA3.1 expression vector (6 well plates
at 0.8μg DNA/well; strain dishes at 5μg DNA/dish) using LipoD293 reagent (3μl/μg
DNA). Twenty-four hours after transfection, medium was changed to adipogenic medium.
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2.7. aP2 luciferase assay
Cells were co-transfected with FLAG-PPARγ2 (0.5 μg) and pCMV-RXRα (0.5 μg) as well
as with the aP2-luciferase construct [20] (0.5 μg) versus salmon sperm DNA. The pCMV-
RXRα plasmid [24] was a gift from Dr. Mark Nanes (Emory University). The aP2-
luciferase construct was from Addgene (plasmid 8858, deposited by Bruce Spiegelman). β-
galactosidase (0.2 μg) was used to control for transfection efficiency in all wells. LipoD293
reagent was used according to the manufacturer’s protocol. The medium was changed to α-
MEM ± 1 μM rosiglitazone 24 h after transfection and treatments applied. Luciferase assays
were performed on cell lysates collected 3 d after transfection with the luciferase assay
system (Promega) and Galacto-Star (Applied Biosystems, Bedford, MA) and measured
using the GloMax Luminometer (Promega).
2.8. Western blotting
Whole cell lysates were prepared as previously described [16, 25] and protein (10-35 μg)
was separated on a polyacrylamide gel before transfer to PVDF membrane. Antibodies
directed against β-catenin (BD Biosciences), aP2 (ProSci, Inc., Poway, CA), active β-
catenin, PPARγ, adiponectin, and β-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA)
were used. The antibody for active β-catenin was specific for the hypo-phosphorylated form
of β-catenin [26]. Secondary antibody conjugated with horseradish peroxidase was detected
by chemiluminescence. Images were acquired with a Hewlett-Packard Scanjet and
densitometry determined using NIH ImageJ, 1.37v.
2.9. Histochemistry
Cultures fixed in 10% formalin were stained with 0.5% oil red O (Poly Scientific, Bay
Shore, NY) to detect cytoplasmic triglyceride droplets.
2.10. Flow cytometry
Bicolor mdMSC were cultured in specified medium for 1-4 d. For flow analysis, single cell
suspensions were prepared by treating cultures with trypsin-EDTA for 5 min to release cells
from the culture dish. Cells from multiple wells were pooled into a single sample and
centrifuged. The cell pellet was re-suspended in PBS containing 1% paraformaldehyde and
stored at 4°C until flow analysis was performed using a BD LSRII cytometer. mdMSC from
wild-type C57BL/6 mice were used as an unstained, negative control for flow analysis.
Positive GFP expression was defined as the intensity corresponding to 0.1% positive cells in
the negative control. For cultures evaluated by fluorescent microscopy (IX81, Nikon), PBS
containing 2% paraformaldehyde was added to wells and plates were stored at 4°C until
microscopy was performed. For sorting of bicolor mdMSC, cells were cultured in specified
medium in 100 mm diameter dishes. Single cell suspensions were prepared as described
above and cells from multiple dishes were pooled into a single sample. Sorting of bicolor
mdMSC by GFP intensity was performed under sterile conditions using a Dako MoFlo
sorter at the UNC Flow Cytometry Core Facility. Sorted mdMSC were replated (15,000
cells/cm2) for further culture.
2.11. Real-time RT-PCR
Total RNA was isolated and reverse transcribed as in [25]. Aliquots of cDNA were diluted
5-5000 fold to generate relative standard curves. Osterix and 18S primers were as previously
described [16]. PCR products were normalized to 18S amplicons in the RT sample.
2.12. Statistical analysis
Results are expressed as the mean ± SEM. Statistical significance was evaluated by t-test,
one-way ANOVA with a Tukey’s post hoc test, or two-way ANOVA with a Bonferroni
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posttest (GraphPad Prism 5.04) where appropriate. All experiments were replicated at least
once. Densitometry data were compiled from three separate experiments.
3. Results
3.1. GSK3β inhibition disrupts rosiglitazone-directed adipogenesis through β-catenin
To study potential mechanical effects on PPARγ transcriptional activity and regulation of its
target genes, we used the thiazolidinedione PPARγ ligand rosiglitazone to induce
adipogenesis in marrow derived MSC. Rosiglitazone in combination with insulin and
dexamethasone rapidly stimulated adipogenic differentiation as evidenced by expression of
adipogenic proteins (Fig. 1A). mdMSC expressed PPARγ1 but not PPARγ2 in the absence
of adipogenic stimuli (left lane). Treatment with rosiglitazone increased expression of both
PPARγ1 and PPARγ2. aP2 and adiponectin, gene targets of PPARγ2, were detected by
immunoblot in day 2 cultures and protein levels were further increased on day 4. The levels
of active and total β-catenin were reduced in day 4 cultures in response to rosiglitazone
treatment compared to untreated cultures (left lane).
Cellular β-catenin accumulation stimulated via canonical Wnt signaling or pharmacologic
inhibition of GSK3β disrupts adipogenesis and reduces expression of PPARγ [16]. We here
asked whether inhibition of GSK3β could limit rosiglitazone-induced adipogenesis in
mdMSC, e.g., at targets distal to PPARγ activation. Rosiglitazone induction of PPARy2,
aP2, and adiponectin proteins was blocked by treatment with the GSK3β inhibitor
SB415286 (Fig. 1B). Concomitantly, SB415286 also limited accumulation of lipid droplets
(Fig. 1C). The ratio of active β-catenin/tubulin was increased 60% with SB415286
treatment, from a ratio of 0.9 in cultures without SB415286 to a ratio of 1.4 in cultures
treated with 30μM SB415286 (Fig. 1B).
As GSK3β inhibition affects multiple targets, we queried whether the increase in β-catenin
was responsible for restraining rosiglitazone-directed adipogenesis. The blot for active β-
catenin showed near complete knockdown by siRNA targeting β-catenin (Fig. 1D). In
cultures where β-catenin was silenced, SB415286 treatment did not block expression of the
adipogenic proteins PPARy2, aP2, and adiponectin stimulated by rosiglitazone. Thus,
GSK3β inhibition restricts PPARγ2 expression and disrupts rosiglitazone-induced
adipogenesis through β-catenin.
3.2. Mechanical strain inhibits adipogenesis induced by rosiglitazone
We next evaluated the ability of mechanical signals to limit adipogenesis induced by
rosiglitazone. Daily treatment with mechanical strain (2%, 0.17Hz, 3600 cycles) applied for
3 consecutive days to mdMSC during rosiglitazone treatment inhibited adipogenic
differentiation. Shown in Fig. 2A, strain reduced induction of PPARγ2 as well as the
expression of its downstream targets, aP2 and adiponectin, in the presence of rosiglitazone
treatments (1-25μM). The effect of strain to limit rosiglitazone-induced accumulation of
adipogenic proteins was verified by densitometry performed over a series of 3 experiments
(Fig. 2B). Compared to the control unstrained cultures, strain significantly reduced
expression of PPARγ2, aP2, and adiponectin by 88 ± 3%, 64 ± 5%, and 77 ± 4%,
respectively.
To investigate the role of β-catenin in mediating strain inhibition of rosiglitazone-directed
adipogenesis, β-catenin was silenced. In cultures where the level of active β-catenin protein
was reduced by more than 80% by siRNA treatment, adiponectin protein expression was not
inhibited by application of strain (Fig. 2C). In contrast, strain inhibition of PPARγ2
persisted in one of two experiments where β-catenin was silenced. This suggests that strain
has effects on PPARγ2 activity as well as PPARγ2 expression, which we address in the
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next section, and indicates a primary role for β-catenin in strain repression of rosiglitazone’s
induction of adiponectin.
3.3. Mechanical strain interferes with PPARγ action
As discussed above, treatment with either a daily mechanical regimen or with the GSK3β
inhibitor SB415286 limited induction of PPARγ2 expression by rosiglitazone. The
repression of aP2 and adiponectin by these treatments could be ascribed to either the
reduction in PPARγ2 expression or to a repression of PPARγ activity. To delineate an
effect of β-catenin distal to PPARγ2 expression, we set out to determine whether
adipogenesis induced by rosiglitazone could by inhibited in mdMSC where PPARγ2 was
overexpressed. A PPARγ2-FLAG vector was transfected into mdMSC, and adipogenic
medium containing rosiglitazone was added to cultures 24 hours after transfection. By 4
days post-transfection, PPARγ2 protein was strongly expressed in mdMSC transfected with
the overexpression vector (Fig. 3A). GSK3β inhibition effectively blocked adipogenesis in
mdMSC despite abundant PPARγ2 expression, indicated by limited expression of aP2 and
adiponectin proteins in SB415286 treated cultures overexpressing PPARγ2. These data
indicate that β-catenin interferes with induction of PPARγ2 target genes.
A luciferase construct driven by the aP2 promoter [20] was used to evaluate the effect of
GSK3β inhibition on PPARγ transactivation. In cells overexpressing PPARγ2-FLAG and
RXRα SB415286 treatment decreased aP2 transcription by 50 ± 2% in basal medium
without rosiglitazone (Fig. 3B). The addition of rosiglitazone increased PPARγ2/RXRα
induced transcription of aP2 by 2-fold. SB415286 treatment significantly decreased aP2
transcription by 34 ± 6% even in the presence of rosiglitazone. Thus, notwithstanding high
levels of PPARγ2 and an activating ligand, GSK3β inhibition reduced transcriptional
activity of PPARγ2, suggesting that β-catenin does limit PPARγ2 transactivation in
mdMSC.
Mechanical strain also effectively limited rosiglitazone-induced adipogenesis in mdMSC
overexpressing PPARγ2 (Fig. 3C). The daily strain regimen reduced expression of both aP2
and adiponectin, although the level of transfected PPARγ2 was unaffected by strain. Next,
the aP2-luciferase construct was used to directly assess strain effects on PPARγ2
transactivation. mdMSC overexpressing PPARγ2/RXRα were treated with rosiglitazone.
When mechanical strain was applied concurrently with rosiglitazone, PPARγ2/RXRα
induced transcription of aP2 was significantly reduced by 18 ± 3% (Fig. 3D). These
experiments indicate that strain inhibition of adipogenesis involves limiting ligand-activated
PPARγ2 target gene transactivation.
3.4. Evaluating adipogenesis in individual cells using an aP2-GFP reporter
Although measuring whole culture expression of adipogenic proteins within a population of
differentiating mdMSC showed that expression of an adipocyte phenotype induced by
rosiglitazone was constrained by mechanical input, this method of analysis did not allow us
to determine where the mechanical block occurred. Limitation of adipogenesis could be
through reducing allocation of undifferentiated cells to the adipocyte lineage, or through
limiting PPARγ action within cells which had already entered the adipocyte lineage.
Adipogenic cultures exposed to a daily strain regimen were found to have an enhanced
potential to enter the osteogenic lineage compared to control adipogenic cultures [16],
suggesting mechanical disruption of adipogenic commitment. To allow analysis at the level
of single cells, we generated a mdMSC population from adult transgenic mice whose cells
contained a GFP reporter driven by a 7.6 kB promoter fragment of the aP2 gene to serve as
an indicator of entry into the adipogenic lineage [23]. The mice also possessed a mCherry
reporter that was positively regulated by SMαA and therefore expressed in MSC [22].
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In the absence of adipogenic supplements (i.e. basal medium), the majority of bicolor
mdMSC (84.1%) were positive for SMαA-mCherry, but negative for aP2-GFP after 3 days
in culture. The total fraction of cells positive for GFP in the basal medium was 8.8% (Fig.
4A). The total fraction of GFP-positive cells increased to 34.3% after 3 days of treatment
with insulin and dexamethasone, a combination shown to induce a gradual adipogenic
differentiation over 7-10 days in mdMSC [13]. The addition of rosiglitazone greatly
accelerated adipogenesis: GFP accumulation was seen in 89.8% of cells after 3 days in
culture and GFP expression was confirmed by microscopy (Fig. 4B). In the presence of
adipogenic supplements, the majority of GFP-positive cells were also positive for SMαA-
mCherry.
In the presence of rosiglitazone, activation of the aP2-GFP construct was rapid. A detectable
level of GFP was measured in 59% of cells after only 1 day of treatment (Fig. 4C). This
early aP2 response may be due to activation of PPARγ1 [27], which is constitutively
expressed in mdMSC (Fig. 4D). Shown in 4C, the fraction of cells positive for GFP
continued to increase from day 1 to 4 along with a significant increase in GFP median
fluorescence. Thus, accrual of GFP protein increased along with expression of PPARγ2 and
other adipogenic proteins (Fig. 4D).
These findings indicate that aP2-GFP reporter intensity reflects progression along the
adipogenic lineage. mdMSC treated with rosiglitazone, insulin, and dexamethasone for 3
days were sorted into two subpopulations based upon GFP intensity. The subpopulation with
the highest GFP intensity (top quintile of total cell population; defined as the upper fraction
or “UF”) was separated from the remainder of the cell population (defined as the lower
fraction or “LF”). Comparing the adipogenic proteins present in the sorted cell populations
revealed that the upper fraction contained more PPARγ2, aP2, and adiponectin proteins
compared to the lower fraction (Fig. 5A). This data indicates that the upper fraction of GFP-
expressing cells represented a more committed adipogenic population compared to the
remainder of GFP-expressing cells.
To further characterize the two cell subpopulations defined by GFP intensity, we asked
whether there was a difference in their multipotentiality. After 3 days in adipogenic medium
containing rosiglitazone, mdMSC were sorted by GFP intensity into the upper and lower
fractions (UF; LF). Following sorting, each fraction was re-plated for further culture. To
assess multipotentiality, the sorted fractions were treated with BMP-2 for 2 days at a dose
known to induce osteogenesis [16]. In the absence of BMP-2, there was minimal expression
of the osteoblast transcription factor osterix in either fraction (Fig. 5B). Treatment with
BMP-2 induced expression of osterix by 42.3-fold in the lower fraction of rosiglitazone-
treated cultures. Although BMP-2 did increase osterix expression in the upper fraction by
11.6-fold, the increase in osterix was significantly less than that in the lower fraction. In
sum, adipogenic mdMSC expressing high levels of aP2-GFP were resistant to an osteogenic
stimulus, reflecting a population of mdMSC terminally committed to an adipocyte lineage.
3.5. Strain restricts appearance of highly adipogenic populations
We next used mdMSC containing the aP2-GFP construct to evaluate how mechanical strain
affected the proportion of cells with high and low GFP expression by addressing the
following question: would mechanical input reduce global aP2-GFP expression, or
specifically limit the proportion of cells in the upper fraction enriched with committed
adipocytes? First, we demonstrated that daily application of strain blocked adipogenesis
induced by rosiglitazone in the mdMSC containing the aP2-GFP construct. Expression of
PPARγ2, aP2, and adiponectin proteins was strongly decreased in strained cultures (Fig.
6A), and confirmed by densitometry (Fig. 6B). As such, the ability of mechanical input to
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limit expression of adipocyte proteins in mdMSC containing the aP2-GFP construct was
similar to the strain effect in wild-type mdMSC (see Fig. 2A).
We next evaluated strain effects on aP2-GFP expression. Mechanical strain did not
significantly reduce the total number of GFP positive cells induced by rosiglitazone (Fig.
6C) suggesting that the initial aP2-GFP response to rosiglitazone was largely unaffected.
However, the median intensity of GFP expression was decreased by 31 ± 7% in the strained
cultures, an effect that approached significance (p=0.052). This result suggested that strain
might preferentially block the maturation of mdMSC into committed adipocytes. Guided by
the GFP subpopulation analysis as detailed in figure 5, the GFP intensity threshold that
identified the top quintile of GFP-expressing cells in mdMSC cultures was applied to flow
analysis of the strained cultures to measure how strain might alter this highly adipogenic
population. The portion of GFP-expressing cells above this threshold was 10.0 ± 1.2% in
strained cultures, a significant two-fold reduction from the portion of cells above the
threshold in unstrained cultures (20.1 ± 0.1%). Together with the effect of strain to almost
completely block appearance of adipogenic proteins (Fig. 6A), this analysis points to an
effect of mechanical input to prevent late commitment to the adipogenic lineage.
Importantly, as we have shown that the upper fraction of aP2-GFP expressing cells has a
reduced ability to respond to osteogenic cues, the ability of strain to specifically limit the
size of this highly adipogenic population indicates that the multipotentiality of the mdMSC
population is preserved by mechanical strain.
To further test the thesis that mechanical input preserves multipotentiality by limiting
commitment to an adipogenic lineage, we evaluated strain effects on adipogenesis in
mdMSC containing the aP2-GFP construct under conditions where adipogenesis was
stimulated in the absence of an exogenous PPARγ ligand. To this end we used the
cyclooxygenase inhibitor indomethacin, which is a strong enhancer of adipogenesis when
added to medium containing dexamethasone and insulin [28]. When mdMSC containing the
aP2-GFP construct were treated with indomethacin (50μM) in combination with insulin and
dexamethasone, adipogenic differentiation was induced, as indicated by expression of
PPARγ2, aP2, and adiponectin proteins (Fig. 7A). In comparison to indomethacin, the effect
of rosiglitazone (5μM) was more rapid and induced greater expression of adipogenic
proteins during the first 4 days of culture. GFP expression was detected in 61.1% of cells
after 3 days of treatment with indomethacin (Fig. 7B) and was confirmed by microscopy
(Fig. 7C).
FACs sorting was used to divide the cell population into an upper and lower fraction based
upon aP2-GFP intensity as described in Figure 5. Immunoblots of whole cell lysates
prepared from the sorted cell populations revealed that the upper fraction contained more
PPARγ2, aP2, and adiponectin proteins compared to the lower fraction (Fig. 7D), similar to
the sorted populations analyzed in rosiglitazone-treated cultures. When the two sorted
populations were re-plated and exposed to BMP-2 for two days, the upper fraction of
indomethacin-treated cultures was resistant to osteogenic induction by BMP-2 (Fig. 7E).
Accordingly, BMP-2 increased osterix expression by 44.6-fold in the lower fraction but only
16.6-fold in the upper fraction, consistent with adipocyte commitment in the upper fraction.
Application of a daily strain regimen significantly reduced the total number of GFP positive
cells induced by indomethacin by 20%, from 84.5 ± 2.8% in unstrained cultures to 67.6 ±
1.0% in strained cultures after 4 days of treatment (Fig. 7F). To further evaluate strain
effects on the committed adipocyte population, the GFP intensity threshold which identified
the top quintile of GFP-expressing cells in mdMSC cultures was applied to flow analysis of
the strained cultures. The portion of GFP-expressing cells above this threshold was 7.3 ±
1.2% in strained cultures, a significant reduction of more than half from the portion of cells
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above the threshold in unstrained cultures (20.2 ± 0.2%). Consistent with strain effects on
aP2-GFP expression, mechanical strain inhibited expression of adipogenic proteins in
mdMSC stimulated with indomethacin (Fig. 7G). Thus, strain appeared to preferentially
disrupt late maturation of mdMSC into committed adipocytes induced by indomethacin. In
sum, these data indicate that mechanical treatment preserves multipotentiality of mdMSC in
the face of adipogenic stimuli.
4. Discussion
Conditions that promote skeletal fragility, including aging and forced unloading, are
associated with progressive accumulation of adipocytes within the bone marrow. Stem cell
function within the marrow may be negatively impacted by the presence of adipocytes. Not
only does exercise increase bone quantity and reduce skeletal fragility, but it can also reduce
bone marrow adipogenesis. Mechanical factors have direct effects on mesenchymal stem
cells, preventing adipocyte differentiation. In the work presented here, we have shown that
mechanical input blocks adipogenesis and preserves multipotentiality of marrow-derived
MSC under conditions promoting PPARγ activation. Thus, mechanical factors generated by
weight-bearing exercise are potent environmental cues that protect MSC function by
limiting differentiation under strongly adipogenic conditions, thereby benefiting overall
skeletal health.
In this work, the PPARγ ligand rosiglitazone was used to induce adipogenesis to study
mechanical effects on PPARγ2 regulation of target genes. Rosiglitazone treatment led to the
induction of PPARγ2 expression in murine marrow-derived MSC, supporting rapid
adipocyte differentiation, consistent with prior studies evaluating rosiglitazone effects on
MSC [29, 30]. Application of a daily strain regimen inhibited rosiglitazone-induced
expression of PPARγ2, as well as expression of its target genes aP2 and adiponectin,
indicating that mechanical input exerts a primary effect to limit PPARγ induction. However,
mechanical strain also blocked expression of aP2 and adiponectin in the presence of
PPARγ2 overexpression, indicating that inhibition of PPARγ2 action contributes to
mechanical repression of adipogenesis.
Using mdMSC containing an aP2 directed GFP allowed separation by GFP intensity of a
population which had high expression of PPARγ2 and adiponectin; immunoblotting
indicated that the majority of expression of adipogenic proteins derived from the
subpopulation (top quintile) with the highest GFP intensity. Importantly, this most
terminally differentiated population was significantly less responsive to an osteogenic
stimulus. Application of strain to aP2-GFP expressing cells reduced the number of cells
expressing the highest GFP intensity, indicative of the terminally differentiated phenotype,
by at least half, an effect consistent with the reduction in adiponectin and aP2 proteins.
Taken together, this data indicates that mechanical input preserves MSC, in the face of
strong adipogenic stimuli, in a multipotential state. Preservation of multipotentiality is
critical for bone health. Senescent osteoporosis can be attributed, in part, to a reduction in
MSC potential [31].
Marrow-derived MSC containing the aP2-GFP reporter responded rapidly to treatment with
a PPARγ ligand in the MSC population harvested from adult animals used in this study. The
protocol developed by Peister [21] generates a multipotent MSC population which
undergoes rapid adipogenic differentiation [15], markedly faster than adipogenesis observed
in primary cultures [32]. The isolation and expansion protocol may have influenced the
composition of the bicolor mdMSC population used in our study, possibly allowing for a
shift in the mdMSC pool to favor a subpopulation that has enhanced adipogenic potential.
However, despite the fact that the majority of bicolor mdMSC expressed aP2-GFP in
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response to rosiglitazone, a much smaller percentage of these cells went on to become
terminally differentiated adipocytes during this time period.
A role for β-catenin in the mechanical repression of PPARγ2 expression has been
demonstrated for a variety of adipogenic stimuli [12, 13, 15]. In our work, although β-
catenin was not found to have a consistent role in strain inhibition of PPARγ2 expression
induced by rosiglitazone treatment, this pathway was critically involved in the strain effect
on adiponectin. In the case of rosiglitazone induced adipogenesis, mechanically-activated β-
catenin participates in suppression of PPARγ actions. β-catenin has been shown to limit
PPARγ regulated transcription in early adipocytes [18, 33], suggesting a negative
interaction between β-catenin and PPARγ2 itself. This idea is supported by our data
showing that sustained GSK3β inhibition by SB415286, leading to β-catenin accumulation,
decreased aP2-luciferase activity and greatly reduced expression of aP2 and adiponectin in
mdMSC overexpressing PPARγ2.
Our laboratory has defined aspects of mechanical signaling that result in β-catenin
preservation and activation in MSC. Similar to Wnt stimulated β-catenin activation, a
release from tonic GSK3β phosphorylation via mechanical input prevents β-catenin
processing by proteosomes. However, in contradistinction to the canonical Wnt signaling
pathway where GSK3β is sequestered away from β-catenin downstream of the Wnt co-
receptors Lrp and frizzled [34], mechanical stimulation requires activation of mTORC2 [35],
a complex containing mTOR and rictor that is insensitive to rapamycin inhibition [36]. The
target of mTORC2 activation by strain is Akt, which phosphorylates and inactivates GSK3β
[35, 37], leading to β-catenin activation. Importantly, a recent in vivo study showed that
exercise increases GSK3β phosphorylation, resulting in increased β-catenin and decreased
PPARγ measured in lumbar vertebrae of ovariectomized rats [38].
In sum, we have shown that mechanical strain inhibits rosiglitazone-induced adipogenesis in
marrow-derived MSC, a process that involves limiting PPARγ2 expression. Strain can also
regulate events downstream of PPARγ activation, as expression of aP2 and adiponectin is
blocked by strain application in mdMSC overexpressing PPARγ2 treated with rosiglitazone.
Furthermore, we have used mdMSC containing an aP2-GFP construct to demonstrate that
strain preferentially restricts maturation of progenitor cells into committed adipocytes,
preserving multipotentiality of the mdMSC population. As such, mechanically stimulated
MSC are more capable of responding to osteogenic factors. Our data suggest that exercise
should be a useful countermeasure to conditions that promote adipogenesis within bone
marrow, including aging, immobility, and pharmacologic treatments that activate PPARγ.
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abbreviations
mdMSC marrow-derived mesenchymal stem cells
FBS fetal bovine serum
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SMαA smooth muscle alpha-actin
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• Mechanical strain inhibits rosiglitazone-induced adipogenesis in marrow-
derived MSC
• Strain repression of adipogenesis involves limiting PPARγ2 expression
• Mechanical strain blocks expression of aP2 and adiponectin in mdMSC
overexpressing PPARγ2 treated with rosiglitazone
• mdMSC containing an aP2-GFP construct were used to demonstrate that strain
preferentially restricts maturation of progenitor cells into committed adipocytes
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Fig. 1. GSK3β inhibition disrupts rosiglitazone-directed adipogenesis
(A) mdMSC were cultured in adipogenic medium containing 5 μg/ml insulin, 0.1 μM
dexamethasone, and rosiglitazone (R) at 1, 5, or 25 μM and compared to mdMSC cultured
in basal medium only (B) for 4 d. Total cellular proteins were immunoblotted for designated
proteins on the indicated days, with β-tubulin used as a loading control. (B) The GSK3β
inhibitor SB415286 (SB415) was added to mdMSC in adipogenic medium with 5 μM
rosiglitazone and proteins were analyzed by immunoblotting on day 3. (C) Oil red O
staining after treatment as in (B) for 4 d. (D) Immunoblots of total cellular proteins from
mdMSC transfected with nonsense siRNA (- siCat) or siRNA targeting β-catenin (+ siCat),
then cultured in adipogenic medium with 1 μM rosiglitazone ± 30μM SB415286 for 3 d.
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Fig. 2. Mechanical strain inhibits adipogenesis induced by rosiglitazone
(A) mdMSC in adipogenic medium containing rosiglitazone (Rosi) at 1, 5, or 25 μM were
exposed to a daily strain regimen × 3 d, and total cellular proteins were immunoblotted for
designated proteins. (B) Densitometric analyses of PPARγ2, aP2, and adiponectin were
performed (n = 3 experiments) after treatment as in (A) with adipogenic medium containing
5 μM rosiglitazone. * p<0.001 shows significant difference from unstrained control. (C)
Immunoblots of total cellular proteins from mdMSC transfected with nonsense siRNA (-
siCat) or siRNA targeting β-catenin (+ siCat), then cultured in adipogenic medium with 1
μM rosiglitazone ± daily strain for 3 d. Blots from two different experiments are included.
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Fig. 3. Mechanical strain interferes with PPARγ function
(A) mdMSC were transfected with an overexpression vector for PPARγ2 or control empty
vector. Adipogenic medium including rosiglitazone ± 30μM SB415286 was added 24 h later
and cells were analyzed at 3 d by immunoblot for designated proteins. (B) mdMSC were co-
transfected with overexpression vectors for PPARγ2 and RXRα as well as an aP2-luciferase
(aP2-luc) vector. β-galactosidase was used to control for transfection efficiency. The GSK3β
inhibitor SB415286 (SB415) was added to basal medium (- Rosi) or medium including 1
μM rosiglitazone (+ Rosi) 24 h after transfection. aP2-luc reporter assay was performed 2 d
later. Data were compiled from three experiments. ** p<0.001 shows significant difference
from medium without SB415. (C) mdMSC overexpressing PPARγ2 were cultured in
adipogenic medium including rosiglitazone ± daily strain for 3 d and proteins analyzed by
immunoblotting. (D) mdMSC were co-transfected with PPARγ2 and RXRα, as well as aP2-
luc vector and β-galactosidase. Strain was applied concurrent with transfection. 24 h after
transfection mdMSC were switched to medium containing 1 μM rosiglitazone and a daily
strain regimen was applied. aP2-luc reporter assay was performed 2 d later. Data were
compiled from three experiments. * p<0.05 shows significant difference from unstrained
control.
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Fig. 4. Evaluating adipogenesis in individual cells using an aP2-GFP reporter
mdMSC contained a GFPtopaz reporter for the aP2 promoter and a mCherry reporter for the
SMαA promoter. (A) Cells were cultured in designated medium for 3 d prior to analysis by
flow cytometry. Dex = dexamethasone; Rosi = rosiglitazone. (B) Fluorescent microscopy
showing expression of aP2-GFP in individual cells after 4 d in adipogenic medium
containing rosiglitazone, with a phase contrast image included to indicate cellular
morphology. (C) Histograms (left) for aP2-GFP expression after 1 and 4 d in adipogenic
medium. Vertical line indicates threshold for FITC intensity corresponding to positive GFP
expression. Graph (right) showing positive GFP cell fraction and median GFP intensity
versus days in adipogenic medium. Three experiments grouped for statistical analyses are
shown in the graph. Days not sharing a letter are significantly different (p<0.05). (D)
Immunoblots of total cellular proteins from cultures in adipogenic medium including
rosiglitazone for 2 or 4 d compared to culture in basal (B) medium only.
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Fig. 5. Sorting by GFP intensity identifies a committed adipogenic population
mdMSC containing the aP2-GFP construct were cultured in adipogenic medium including 5
μM rosiglitazone for 3d then sorted into two subpopulations based upon GFP intensity. The
subpopulation with the highest GFP intensity (top quintile of total cell population; defined as
the upper fraction or “UF”) was separated from the remainder of the cell population (defined
as the lower fraction or “LF”). (A) Immunoblots of total cellular proteins isolated from each
subpopulation. (B) The sorted subpopulations were re-plated into adherent culture. On the
following day, cultures were treated with 125 ng/ml BMP-2 for 4 d. Designated mRNA was
amplified by real-time RT-PCR. Representative data are shown as mean ± SEM and the
experiment was repeated two times. * p<0.05, *** p<0.001 shows significant difference
from vehicle.
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Fig. 6. Strain limits a committed adipogenic population induced by rosiglitazone
(A) mdMSC containing the aP2-GFP construct were cultured in adipogenic medium
containing 5 μM rosiglitazone and exposed to a daily strain regimen × 4 d. Total cellular
proteins were immunoblotted for designated proteins. (B) Densitometric analyses of
PPARγ2, aP2, and adiponectin were performed (n = 3 experiments) after treatment as in
(A). * p<0.05, ** p<0.01 shows significant difference from unstrained control. (C) mdMSC
treated as in (A) were evaluated by flow analysis. Histograms (left) for aP2-GFP expression
in unstrained, control cultures or cultures subjected to a daily strain regimen. Left vertical
line indicates threshold for FITC intensity corresponding to positive GFP expression and
right vertical line (U20) indicates threshold for FITC intensity corresponding to upper
quintile of GFP expression in control cultures. Histogram data were analyzed (n = 3
experiments) for median GFP intensity (top right) and % GFP positive cell fraction
corresponding to each threshold level (bottom right). ** p<0.01 shows significant difference
from unstrained control.
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Fig. 7. Strain limits a committed adipogenic population induced by indomethacin
mdMSC containing the aP2-GFP construct were cultured in adipogenic medium containing
insulin, dexamethasone, and 50 μM indomethacin (Indo). (A) Immunoblots of total cellular
proteins from mdMSC cultured in adipogenic medium including Indo or 5 μM rosiglitazone
(Rosi) for 2 or 4 d. (B) Flow analysis of day 3 cultures. (C) Fluorescent microscopy showing
expression of aP2-GFP in individual cells after 4 d in adipogenic medium containing
inndomethacin, with a phase contrast image included to indicate cellular morphology. (D)
mdMSC were cultured in adipogenic medium including indomethacin for 4d, and then
sorted into two subpopulations based upon GFP intensity as described in figure 5.
Immunoblots of total cellular proteins isolated from the upper fraction (UF) and the lower
fraction (LF). (E) The sorted subpopulations were re-plated into adherent culture, and then
treated with 125 ng/ml BMP-2 for 2 d. Designated mRNA was amplified by real-time RT-
PCR. Data were compiled from two experiments. * p<0.01, ** p<0.001 shows significant
difference from vehicle. (F) mdMSC in adipogenic medium were exposed to a daily strain
regimen × 5 d and evaluated by flow analysis. Histograms (left) for aP2-GFP expression in
unstrained, control cultures or cultures subjected to a daily strain regimen. Left vertical line
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indicates threshold for FITC intensity corresponding to positive GFP expression and right
vertical line (U20) indicates threshold for FITC intensity corresponding to upper quintile of
GFP expression in control cultures. Histogram data (n = 3 experiments) were analyzed for %
GFP positive cell fraction corresponding to each threshold level (right). * p<0.01, **
p<0.001 shows significant difference from unstrained control. (G) Immunoblots of total
cellular proteins from mdMSC treated as in (F).
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